Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRON
CRON logo

CRON Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cronos Group Inc (CRON) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.440
1 Day change
-2.40%
52 Week Range
3.430
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cronos Group Inc (CRON) is not a strong buy for a beginner, long-term investor at this time. While the company shows positive revenue growth and has received favorable analyst ratings, the recent financial performance, lack of significant trading signals, and weak technical indicators suggest holding off on investment for now.

Technical Analysis

The MACD is slightly positive but contracting, RSI is neutral at 47.079, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 2.524, with resistance at 2.633 and support at 2.415. Overall, technical indicators do not suggest a strong entry point.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data shows a significantly bullish sentiment with a very low put-call ratio, but this alone is insufficient to justify a buy.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • Analysts have initiated coverage with Buy ratings and price targets in the C$4.25-C$4.50 range, citing strong Canadian cannabis brands and potential profitability improvements. Revenue growth of 46.96% YoY in Q4 2025 is also a positive sign.

Neutral/Negative Catalysts

  • Net income dropped by -104.15% YoY, and EPS fell to 0, indicating poor profitability. The stock's recent trend shows a high probability of further decline (-9.96% in the next month). No recent news or significant insider/hedge fund activity to drive momentum.

Financial Performance

In Q4 2025, revenue increased by 46.96% YoY to $44.53M, and gross margin improved to 35.45%. However, net income dropped significantly to -$1.82M (-104.15% YoY), and EPS fell to 0 (-100% YoY), reflecting weak profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have initiated Buy ratings with price targets of C$4.25-C$4.50, citing strong market positioning and operational efficiency. However, these ratings are long-term focused and do not align with the current weak financial and technical performance.

Wall Street analysts forecast CRON stock price to rise
2 Analyst Rating
Wall Street analysts forecast CRON stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.500
sliders
Low
2.3
Averages
2.72
High
3.14
Current: 2.500
sliders
Low
2.3
Averages
2.72
High
3.14
TD Securities
NULL -> Buy
initiated
$4.50
AI Analysis
2026-02-24
Reason
TD Securities
Price Target
$4.50
AI Analysis
2026-02-24
initiated
NULL -> Buy
Reason
TD Securities initiated coverage of Cronos Group with a Buy rating and C$4.50 price target. Cronos, which has "some of the most iconic Canadian cannabis brands on the market, is well-positioned to improve profitability as it scales the top-line with a lean operating cost base and leading cultivation practices, the analyst tells investors.
Canaccord
Kenric Tyghe
Buy
initiated
$4.25
2026-01-27
Reason
Canaccord
Kenric Tyghe
Price Target
$4.25
2026-01-27
initiated
Buy
Reason
Canaccord analyst Kenric Tyghe initiated coverage of Cronos Group with a Buy rating and C$4.25 price target. While Canada and Israel are the company's two largest markets today, the firm believes that its recent acquisition of CanAdelaar and the expansion of Cronos Growing Company are "the leading edge of transformational change at the company," the analyst tells investors in a note starting coverage of the the Canadian cannabis group.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRON
Unlock Now

People Also Watch